z-logo
open-access-imgOpen Access
Rare De Novo Germline Copy-Number Variation in Testicular Cancer
Author(s) -
Zsofia K. Stadler,
Diane Esposito,
Sohela Shah,
Joseph Vijai,
Boris Yamrom,
Dan Levy,
Yoon-ha Lee,
Jude Kendall,
Anthony Leotta,
Michael Ronemus,
Nichole Hansen,
Kara Sarrel,
Rohini RauMurthy,
Kasmintan A. Schrader,
Noah D. Kauff,
Robert J. Klein,
Steven M. Lipkin,
Rajmohan Murali,
Mark E. Robson,
Joel Sheinfeld,
Darren R. Feldman,
George J. Bosl,
Larry Norton,
Michael Wigler,
Kenneth Offit
Publication year - 2012
Publication title -
the american journal of human genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.661
H-Index - 302
eISSN - 1537-6605
pISSN - 0002-9297
DOI - 10.1016/j.ajhg.2012.06.019
Subject(s) - germline , biology , copy number variation , genetics , cancer , germline mutation , testicular cancer , genome wide association study , loss of heterozygosity , allele , mutation , genome , genotype , gene , single nucleotide polymorphism
Although heritable factors are an important determinant of risk of early-onset cancer, the majority of these malignancies appear to occur sporadically without identifiable risk factors. Germline de novo copy-number variations (CNVs) have been observed in sporadic neurocognitive and cardiovascular disorders. We explored this mechanism in 382 genomes of 116 early-onset cancer case-parent trios and unaffected siblings. Unique de novo germline CNVs were not observed in 107 breast or colon cancer trios or controls but were indeed found in 7% of 43 testicular germ cell tumor trios; this percentage exceeds background CNV rates and suggests a rare de novo genetic paradigm for susceptibility to some human malignancies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom